SEC Form 4 · accession 0001384101-18-000080
VERACYTE, INC. · VCYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher M Hall
Officer — President and COO
Period of report
Oct 31, 2018
Accepted (ET)
Nov 1, 2018 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001384101
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 31, 2018 | M | 3,500 | $2.36 | A | 35,955 | D | |
| Common Stock | Oct 31, 2018 | S | 3,500 | $13.00 | D | 32,455 | D | |
| Common Stock | Oct 31, 2018 | M | 16,927 | $2.68 | A | 49,382 | D | |
| Common StockF2,F3 | Oct 31, 2018 | S | 16,500 | $13.0164 | D | 32,882 | D | |
| Common Stock | Oct 31, 2018 | S | 427 | $14.00 | D | 32,455 | D | |
| Common Stock | Oct 31, 2018 | M | 19,573 | $2.68 | A | 52,028 | D | |
| Common Stock | Oct 31, 2018 | S | 19,573 | $14.00 | D | 32,455 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $2.36 | Oct 31, 2018 | M | 3,500 | A | — | Feb 22, 2021 | Common Stock | 3,500 | 0 | D |
| Stock Option (right to buy)F4 | $2.68 | Oct 31, 2018 | M | 16,927 | A | — | Mar 9, 2022 | Common Stock | 16,927 | 0 | D |
| Stock Option (right to buy)F5 | $2.68 | Oct 31, 2018 | M | 19,573 | A | — | Mar 9, 2022 | Common Stock | 19,573 | 813 | D |
Explanation of responses
- F1The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 25, 2018.
- F2Represents the aggregate of sales effected on the same day at different prices.
- F3Represents weighted average sales price. Sale prices for the transactions range from $13.00 to $13.08. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- F4The option became exercisable upon the grant date.
- F5The option becomes exercisable as to 25% of the shares on March 10, 2013, and the remaining shares vested at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.